Cargando…
Intestinal microbiota: a potential target for the treatment of postmenopausal osteoporosis
Postmenopausal osteoporosis (PMO) is a prevalent metabolic bone disease characterized by bone loss and structural destruction, which increases the risk of fracture in postmenopausal women. Owing to the high morbidity and serious complications of PMO, many efforts have been devoted to its prophylaxis...
Autores principales: | Xu, Xin, Jia, Xiaoyue, Mo, Longyi, Liu, Chengcheng, Zheng, Liwei, Yuan, Quan, Zhou, Xuedong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627629/ https://www.ncbi.nlm.nih.gov/pubmed/28983411 http://dx.doi.org/10.1038/boneres.2017.46 |
Ejemplares similares
-
Probiotics ameliorate alveolar bone loss by regulating gut microbiota
por: Jia, Leming, et al.
Publicado: (2021) -
The Role of Reactive Oxygen Species and Autophagy in Periodontitis and Their Potential Linkage
por: Liu, Chengcheng, et al.
Publicado: (2017) -
Changes in the composition of gut and vaginal microbiota in patients with postmenopausal osteoporosis
por: Yang, Xueli, et al.
Publicado: (2022) -
Gut microbiota signatures and fecal metabolites in postmenopausal women with osteoporosis
por: Wang, Han, et al.
Publicado: (2023) -
SCIMP: A Novel Targeted Gene for Postmenopausal Osteoporosis Progression
por: Sun, Xiaolei, et al.
Publicado: (2023)